Ownership history in Discovery Value Fund · 20 quarters on record
This page tracks every 13F SEC filing in which Discovery Value Fund reported a position in INTELLIA THERAPEUTICS INC (NTLA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 97,976 | -130,725 | -57.2% | 2.35% | $881K | $8.99 |
| 2025 Q3 | UNCHANGED | 228,701 | — | 0% | 7.05% | $3.9M | $17.27 |
| 2025 Q2 | REDUCED | 228,701 | -332,860 | -59.3% | 4.16% | $2.1M | $9.38 |
| 2025 Q1 | UNCHANGED | 561,561 | — | 0% | 5.66% | $4.0M | $7.11 |
| 2024 Q4 | UNCHANGED | 561,561 | — | 0% | 3.76% | $6.5M | $11.66 |
| 2024 Q3 | UNCHANGED | 561,561 | — | 0% | 5.93% | $11.5M | $20.55 |
| 2024 Q2 | UNCHANGED | 561,561 | — | 0% | 6.39% | $12.6M | $22.38 |
| 2024 Q1 | UNCHANGED | 561,561 | — | 0% | 5.35% | $15.4M | $27.51 |
| 2023 Q4 | UNCHANGED | 561,561 | — | 0% | 7.82% | $17.1M | $30.49 |
| 2023 Q3 | UNCHANGED | 561,561 | — | 0% | 9.73% | $17.8M | $31.62 |
As of 2025 Q4 — sorted by position size